Department of Psychiatry, University of Melbourne, Victoria, Australia (Elias, Thomas); Departments of Psychiatry and Radiology, College of Physicians and Surgeons, Columbia University, New York (Sackeim).
Am J Psychiatry. 2021 Mar 1;178(3):229-239. doi: 10.1176/appi.ajp.2020.20030238. Epub 2020 Nov 10.
Resistance to pharmacological agents is commonly encountered in the treatment of acute episodes of mania. In contemporary practice guidelines, electroconvulsive therapy (ECT), once a widely used standalone intervention for mania, is no longer considered a first-line treatment. Stigma, logistics, and ethical factors constrain ECT administration in this condition and lead to its underutilization. However, the past three decades have produced promising research regarding the use of ECT in mania. Randomized controlled trials, albeit in limited numbers, the adoption of ultrabrief ECT, examination of the safety and efficacy of combining ECT with pharmacological agents, including lithium, and use of ECT as a maintenance strategy have enhanced our understanding of how and when to utilize this intervention in mania. In this comprehensive review, the authors summarize the evidence regarding the efficacy and safety of ECT in mania, including related syndromes, such as delirious mania and mixed affective states. The impact of technical parameters, particularly the choice of treatment frequency, electrode placements, and pulse width, are discussed in the light of recent evidence.
在治疗躁狂症急性发作时,经常会遇到对药物治疗的抵抗。在当代实践指南中,电休克疗法(ECT)曾经是一种广泛用于治疗躁狂症的独立干预措施,但不再被认为是一线治疗方法。耻辱感、后勤问题和道德因素限制了ECT 在这种情况下的应用,导致其使用不足。然而,在过去的三十年中,关于ECT 在躁狂症中的应用产生了有希望的研究。尽管数量有限,但随机对照试验、采用超短 ECT、检查 ECT 与包括锂在内的药物联合治疗的安全性和疗效,以及将 ECT 用作维持策略,都增强了我们对如何以及何时在躁狂症中使用这种干预措施的理解。在这篇全面的综述中,作者总结了 ECT 在治疗躁狂症及其相关综合征(如谵妄性躁狂和混合情感状态)中的疗效和安全性的证据。根据最新证据,讨论了技术参数的影响,特别是治疗频率、电极放置和脉冲宽度的选择。